Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 886

Showing 26-50 of 886 citing articles:

An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
Fábio Mambelli, Ana Carolina V. S. C. de Araujo, Jéssica Pires Farias, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access | Times Cited: 1
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
Wilhelm Furnon, Vanessa M. Cowton, Giuditta De Lorenzo, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 1
Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2
Jaclyn M. Long, Vincent N. Miao, Anna H. Owings, et al.
Nature Immunology (2025)
Closed Access | Times Cited: 1
Implications of diversity in sperm size and function for sperm competition and fertility
Montserrat Gomendio, Eduardo R. S. Roldán
The International Journal of Developmental Biology (2008) Vol. 52, Iss. 5-6, pp. 439-447
Open Access | Times Cited: 182
Immune imprinting and next-generation coronavirus vaccines
Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1971-1985
Closed Access | Times Cited: 34
Deep mutational scans of XBB.1.5 and BQ.1.1 reveal ongoing epistatic drift during SARS-CoV-2 evolution
Ashley L. Taylor, Tyler N. Starr
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011901-e1011901
Open Access | Times Cited: 27
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 26
The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection
Zhonglei Wang, Liyan Yang
Nutrients (2023) Vol. 15, Iss. 15, pp. 3443-3443
Open Access | Times Cited: 25
SARS-CoV-2 spike protein receptor-binding domain perturbates intracellular calcium homeostasis and impairs pulmonary vascular endothelial cells
Kai Yang, Shiyun Liu, Yan Han, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 23
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
Romal Stewart, Kexin Yan, Sevannah A. Ellis, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 21
A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2
Cai He, Aqu Alu, Lei Hong, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 20
What makes SARS‐CoV‐2 unique? Focusing on the spike protein
Jingbo Qian, Shi-Chang Zhang, Fang Wang, et al.
Cell Biology International (2024) Vol. 48, Iss. 4, pp. 404-430
Open Access | Times Cited: 11
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 6, pp. e581-e593
Closed Access | Times Cited: 11
The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8
Lujie Fan, Yuzheng Zhou, Xiafei Wei, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 10
Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
Zhuocheng Yao, Lin Zhang, Yuange Duan, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106121-106121
Open Access | Times Cited: 10
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity
MST Monira Begum, Kimiko Ichihara, Otowa Takahashi, et al.
Frontiers in Virology (2024) Vol. 4
Open Access | Times Cited: 10
The emerging challenge of FLiRT variants: KP.1.1 and KP.2 in the global pandemic landscape
Prithiv K R Kumar, Jezina Jayan, Rakesh Sharma, et al.
QJM (2024) Vol. 117, Iss. 7, pp. 485-487
Closed Access | Times Cited: 10
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial
Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, et al.
(2024)
Open Access | Times Cited: 9
Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1
Ilyas Khan, Sunan Li, Hongtao Li, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
A nanogap-enhanced SERS nanotag–based lateral flow assay for ultrasensitive and simultaneous monitoring of SARS-CoV-2 S and NP antigens
Xiaoxian Liu, Xingsheng Yang, Chongwen Wang, et al.
Microchimica Acta (2024) Vol. 191, Iss. 2
Closed Access | Times Cited: 8
Reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients
Humaira Lambarey, Melissa J. Blumenthal, Abeen Chetram, et al.
EBioMedicine (2024) Vol. 100, pp. 104986-104986
Open Access | Times Cited: 8
Electrochemical biosensor for the evaluation of monoclonal antibodies targeting the N protein of SARS-CoV-2 virus
Viktorija Liustrovaitė, Maryia Drobysh, Vilma Ratautaitė, et al.
The Science of The Total Environment (2024) Vol. 924, pp. 171042-171042
Closed Access | Times Cited: 8
COVID-19 vaccines: Immune correlates and clinical outcomes
Shant H. Mahrokhian, Lisa H. Tostanoski, Samuel J. Vidal, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike
Timothy J.C. Tan, Abhishek Kumar Verma, Abby Odle, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Open Access | Times Cited: 8

Scroll to top